Constellation reported capital expenditure of $2.95B for fiscal 2025, +15.0% versus $2.56B in fiscal 2024.
Capex equals 13% of fiscal-year revenue ($22.66B).
The highest single reported period was $1.27B (period ending 2026-03-31).
The latest reported period, 6 months to 2026-06-30, shows $2.52B; the dataset covers 23 reported periods (2020–2026), all from SEC XBRL filings.
Every capital-expenditure figure Constellation has reported to the SEC, unedited. Capex is the XBRL concept PaymentsToAcquirePropertyPlantAndEquipment; a capex/revenue ratio above 100% means the company is investing more than it earns to secure capacity. Each row links to the filing it came from.
| Fiscal year | Capex | YoY |
|---|---|---|
| FY2025 | $2.95B | +15% |
| FY2024 | $2.56B | +6% |
| FY2023 | $2.42B | +43% |
| FY2022 | $1.69B | +27% |
| FY2021 | $1.33B | -24% |
| FY2020 | $1.75B | — |
| Period end | Period | Capex |
|---|---|---|
| 2026-06-30 | FY2026 6 mo. cumulative | $2.52B |
| 2026-03-31 | FY2026 Q1 | $1.27B |
| 2025-12-31 | FY2025 FY | $2.95B |
| 2025-09-30 | FY2025 9 mo. cumulative | $1.96B |
| 2025-06-30 | FY2025 6 mo. cumulative | $1.57B |
| 2025-03-31 | FY2025 Q1 | $806M |
| 2024-12-31 | FY2024 FY | $2.56B |
| 2024-09-30 | FY2024 9 mo. cumulative | $1.84B |
| 2024-06-30 | FY2024 6 mo. cumulative | $1.28B |
| 2024-03-31 | FY2024 Q1 | $738M |
| 2023-12-31 | FY2023 FY | $2.42B |
| 2023-09-30 | FY2023 9 mo. cumulative | $1.74B |
| 2023-06-30 | FY2023 6 mo. cumulative | $1.34B |
| 2023-03-31 | FY2023 Q1 | $660M |
| 2022-12-31 | FY2022 FY | $1.69B |
| 2022-09-30 | FY2022 9 mo. cumulative | $1.09B |
| 2022-06-30 | FY2022 6 mo. cumulative | $800M |
| 2022-03-31 | FY2022 Q1 | $410M |
| 2021-12-31 | FY2021 FY | $1.33B |
| 2021-09-30 | FY2021 9 mo. cumulative | $1.09B |
| 2021-06-30 | FY2021 6 mo. cumulative | $719M |
| 2021-03-31 | FY2021 Q1 | $382M |
| 2020-12-31 | FY2020 FY | $1.75B |
Source: SEC XBRL company-concept API, concept PaymentsToAcquirePropertyPlantAndEquipment, CIK 1868275. See Methodology.